n-(2-chloroethyl)-n-nitrosoacetamide has been researched along with Brain Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bataille, B; Blanc, JL; Chantereau, T; Guilhot, J; Karayan-Tapon, L; Kusy, S; Lapierre, F; Larsen, CJ; Wager, M | 1 |
| Nagane, M | 1 |
| Chen, ZP; Garcia, Y; Langleben, A; Malapetsa, A; Mohr, G; Panasci, LC; Tampieri, D; Yarosh, D | 1 |
| Kohda, K; Mineura, K; Takahashi, M; Watanabe, K | 1 |
| Ali-Osman, F; Berger, MS; Griffin, B; Livingston, RB; Spence, AM | 1 |
| Dean, PN; Deen, DF; Gray, JW; Linfoot, PA; Marton, LJ | 1 |
1 review(s) available for n-(2-chloroethyl)-n-nitrosoacetamide and Brain Neoplasms
| Article | Year |
|---|---|
[Chemotherapy for malignant gliomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; DNA Modification Methylases; DNA Repair; DNA Repair Enzymes; Drug Resistance, Neoplasm; Glioma; Humans; Nitroso Compounds; Survival Rate; Temozolomide; Tumor Suppressor Proteins | 2007 |
2 trial(s) available for n-(2-chloroethyl)-n-nitrosoacetamide and Brain Neoplasms
| Article | Year |
|---|---|
Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; DNA Methylation; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Middle Aged; Nitroso Compounds; O(6)-Methylguanine-DNA Methyltransferase; Prognosis; Promoter Regions, Genetic; Treatment Outcome | 2004 |
Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure.
Topics: Adult; Brain Neoplasms; Cisplatin; Drug Evaluation; Female; Glioma; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Nitroso Compounds | 1992 |
3 other study(ies) available for n-(2-chloroethyl)-n-nitrosoacetamide and Brain Neoplasms
| Article | Year |
|---|---|
Relationship between O6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Brain Neoplasms; DNA Modification Methylases; Drug Resistance, Neoplasm; Female; Glioma; Guanine; Humans; Male; Middle Aged; Nitroso Compounds; Tumor Cells, Cultured | 1999 |
O6-(fluorobenzyl)guanine and chloroethylnitrosourea in xenografted rat brain tumor in vivo.
Topics: Animals; Benzyl Compounds; Brain Neoplasms; Cell Division; DNA Damage; DNA, Neoplasm; Guanine; Mice; Mice, Nude; Nimustine; Nitroso Compounds; O(6)-Methylguanine-DNA Methyltransferase; Rats; Transplantation, Heterologous | 2000 |
Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
Topics: Alkylating Agents; Animals; Brain Neoplasms; Carbamates; Carmustine; Cell Cycle; Cell Line; Cell Survival; Cross-Linking Reagents; Ethylnitrosourea; Lomustine; Nitroso Compounds; Nitrosourea Compounds; Rats; Structure-Activity Relationship | 1986 |